The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BridgeBio Oncology Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Dec 2024 to 31 Dec 2025.
BridgeBio Oncology Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 1210%, a 45% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)
BridgeBio Oncology Therapeutics, Inc. Quarterly Current Ratio (%)
Period
Value
YoY Chg
Change %
Date
Q4 2025
1210%
+377%
+45%
31 Dec 2025
Q3 2025
1065%
30 Sep 2025
Q2 2025
673%
30 Jun 2025
Q1 2025
758%
31 Mar 2025
Q4 2024
833%
31 Dec 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.